Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells. [electronic resource]
- Cancer communications (London, England) 09 2018
- 57 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
2523-3548
10.1186/s40880-018-0327-7 doi
Female Humans Hyaluronan Receptors--metabolism RNA, Small Interfering--genetics Triple Negative Breast Neoplasms--genetics